 | • レポートコード：MRC2-11QY10917 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心房細動（AF）治療のグローバル市場について調査・分析したレポートです。種類別（薬品、非手術的処置、手術的処置）市場規模、用途別（病院、クリニック、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心房細動（AF）治療の競争状況、市場シェア ・世界の心房細動（AF）治療市場：種類別市場規模 2015年-2020年（薬品、非手術的処置、手術的処置） ・世界の心房細動（AF）治療市場：種類別市場規模予測 2021年-2026年（薬品、非手術的処置、手術的処置） ・世界の心房細動（AF）治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外来手術センター） ・世界の心房細動（AF）治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来手術センター） ・北米の心房細動（AF）治療市場分析：米国、カナダ ・ヨーロッパの心房細動（AF）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心房細動（AF）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心房細動（AF）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心房細動（AF）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Abbott、Medtronic、Boston Scientific、Siemens、Biotronik、Koninklijke Philips、AtriCure、CardioFocus、MicroPort Scientific、Sichuan Jinjiang Electronic Science and Technology ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria. Often it starts as brief periods of abnormal beating which become longer and possibly constant over time. Often episodes have no symptoms. Occasionally there may be heart palpitations, fainting, lightheadedness, shortness of breath, or chest pain. The disease is associated with an increased risk of heart failure, dementia, and stroke. It is a type of supraventricular tachycardia.
Geographically, the Americas is anticipated to dominate the global atrial fibrillation market owing to a the rise in the adoption of innovative technologies and procedures for the treatment of atrial fibrillation, and advanced healthcare facilities and infrastructure.
Market Analysis and Insights: Global Atrial Fibrillation Treatment Market
The global Atrial Fibrillation Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Atrial Fibrillation Treatment Scope and Market Size
Atrial Fibrillation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atrial Fibrillation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Abbott
Medtronic
Boston Scientific
Siemens
Biotronik
Koninklijke Philips
AtriCure
CardioFocus
MicroPort Scientific
Sichuan Jinjiang Electronic Science and Technology
Market segment by Type, the product can be split into
Medications
Non-Surgical Procedures
Surgical Procedures
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Atrial Fibrillation Treatment Revenue
1.4 Market by Type
1.4.1 Global Atrial Fibrillation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medications
1.4.3 Non-Surgical Procedures
1.4.4 Surgical Procedures
1.5 Market by Application
1.5.1 Global Atrial Fibrillation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Atrial Fibrillation Treatment Market Perspective (2015-2026)
2.2 Global Atrial Fibrillation Treatment Growth Trends by Regions
2.2.1 Atrial Fibrillation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Atrial Fibrillation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Atrial Fibrillation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Atrial Fibrillation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Atrial Fibrillation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Atrial Fibrillation Treatment Players by Market Size
3.1.1 Global Top Atrial Fibrillation Treatment Players by Revenue (2015-2020)
3.1.2 Global Atrial Fibrillation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Atrial Fibrillation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Atrial Fibrillation Treatment Market Concentration Ratio
3.2.1 Global Atrial Fibrillation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Atrial Fibrillation Treatment Revenue in 2019
3.3 Atrial Fibrillation Treatment Key Players Head office and Area Served
3.4 Key Players Atrial Fibrillation Treatment Product Solution and Service
3.5 Date of Enter into Atrial Fibrillation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Atrial Fibrillation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Atrial Fibrillation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Atrial Fibrillation Treatment Market Size by Application (2015-2020)
5.2 Global Atrial Fibrillation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Atrial Fibrillation Treatment Market Size (2015-2020)
6.2 Atrial Fibrillation Treatment Key Players in North America (2019-2020)
6.3 North America Atrial Fibrillation Treatment Market Size by Type (2015-2020)
6.4 North America Atrial Fibrillation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Atrial Fibrillation Treatment Market Size (2015-2020)
7.2 Atrial Fibrillation Treatment Key Players in Europe (2019-2020)
7.3 Europe Atrial Fibrillation Treatment Market Size by Type (2015-2020)
7.4 Europe Atrial Fibrillation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Atrial Fibrillation Treatment Market Size (2015-2020)
8.2 Atrial Fibrillation Treatment Key Players in China (2019-2020)
8.3 China Atrial Fibrillation Treatment Market Size by Type (2015-2020)
8.4 China Atrial Fibrillation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Atrial Fibrillation Treatment Market Size (2015-2020)
9.2 Atrial Fibrillation Treatment Key Players in Japan (2019-2020)
9.3 Japan Atrial Fibrillation Treatment Market Size by Type (2015-2020)
9.4 Japan Atrial Fibrillation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Atrial Fibrillation Treatment Market Size (2015-2020)
10.2 Atrial Fibrillation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Atrial Fibrillation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Atrial Fibrillation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Atrial Fibrillation Treatment Market Size (2015-2020)
11.2 Atrial Fibrillation Treatment Key Players in India (2019-2020)
11.3 India Atrial Fibrillation Treatment Market Size by Type (2015-2020)
11.4 India Atrial Fibrillation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Atrial Fibrillation Treatment Market Size (2015-2020)
12.2 Atrial Fibrillation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Atrial Fibrillation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Atrial Fibrillation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Atrial Fibrillation Treatment Introduction
13.1.4 Johnson & Johnson Revenue in Atrial Fibrillation Treatment Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Atrial Fibrillation Treatment Introduction
13.2.4 Abbott Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview
13.3.3 Medtronic Atrial Fibrillation Treatment Introduction
13.3.4 Medtronic Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Boston Scientific
13.4.1 Boston Scientific Company Details
13.4.2 Boston Scientific Business Overview
13.4.3 Boston Scientific Atrial Fibrillation Treatment Introduction
13.4.4 Boston Scientific Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.4.5 Boston Scientific Recent Development
13.5 Siemens
13.5.1 Siemens Company Details
13.5.2 Siemens Business Overview
13.5.3 Siemens Atrial Fibrillation Treatment Introduction
13.5.4 Siemens Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.5.5 Siemens Recent Development
13.6 Biotronik
13.6.1 Biotronik Company Details
13.6.2 Biotronik Business Overview
13.6.3 Biotronik Atrial Fibrillation Treatment Introduction
13.6.4 Biotronik Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.6.5 Biotronik Recent Development
13.7 Koninklijke Philips
13.7.1 Koninklijke Philips Company Details
13.7.2 Koninklijke Philips Business Overview
13.7.3 Koninklijke Philips Atrial Fibrillation Treatment Introduction
13.7.4 Koninklijke Philips Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.7.5 Koninklijke Philips Recent Development
13.8 AtriCure
13.8.1 AtriCure Company Details
13.8.2 AtriCure Business Overview
13.8.3 AtriCure Atrial Fibrillation Treatment Introduction
13.8.4 AtriCure Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.8.5 AtriCure Recent Development
13.9 CardioFocus
13.9.1 CardioFocus Company Details
13.9.2 CardioFocus Business Overview
13.9.3 CardioFocus Atrial Fibrillation Treatment Introduction
13.9.4 CardioFocus Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.9.5 CardioFocus Recent Development
13.10 MicroPort Scientific
13.10.1 MicroPort Scientific Company Details
13.10.2 MicroPort Scientific Business Overview
13.10.3 MicroPort Scientific Atrial Fibrillation Treatment Introduction
13.10.4 MicroPort Scientific Revenue in Atrial Fibrillation Treatment Business (2015-2020)
13.10.5 MicroPort Scientific Recent Development
13.11 Sichuan Jinjiang Electronic Science and Technology
10.11.1 Sichuan Jinjiang Electronic Science and Technology Company Details
10.11.2 Sichuan Jinjiang Electronic Science and Technology Business Overview
10.11.3 Sichuan Jinjiang Electronic Science and Technology Atrial Fibrillation Treatment Introduction
10.11.4 Sichuan Jinjiang Electronic Science and Technology Revenue in Atrial Fibrillation Treatment Business (2015-2020)
10.11.5 Sichuan Jinjiang Electronic Science and Technology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Atrial Fibrillation Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Atrial Fibrillation Treatment Revenue
Table 3. Ranking of Global Top Atrial Fibrillation Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Atrial Fibrillation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medications
Table 6. Key Players of Non-Surgical Procedures
Table 7. Key Players of Surgical Procedures
Table 8. Global Atrial Fibrillation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Atrial Fibrillation Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Atrial Fibrillation Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Atrial Fibrillation Treatment Market Share by Regions (2015-2020)
Table 12. Global Atrial Fibrillation Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Atrial Fibrillation Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Atrial Fibrillation Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Atrial Fibrillation Treatment Players
Table 19. Global Atrial Fibrillation Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Atrial Fibrillation Treatment Market Share by Players (2015-2020)
Table 21. Global Top Atrial Fibrillation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation Treatment as of 2019)
Table 22. Global Atrial Fibrillation Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Atrial Fibrillation Treatment Product Solution and Service
Table 25. Date of Enter into Atrial Fibrillation Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Atrial Fibrillation Treatment Market Size Share by Type (2015-2020)
Table 29. Global Atrial Fibrillation Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Atrial Fibrillation Treatment Market Size Share by Application (2015-2020)
Table 31. Global Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Atrial Fibrillation Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 35. North America Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 37. North America Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 41. Europe Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 43. Europe Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 47. China Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 49. China Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 53. Japan Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 55. Japan Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 59. Southeast Asia Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 65. India Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 67. India Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Atrial Fibrillation Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Atrial Fibrillation Treatment Market Share (2019-2020)
Table 71. Central & South America Atrial Fibrillation Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Atrial Fibrillation Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Atrial Fibrillation Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Atrial Fibrillation Treatment Market Share by Application (2015-2020)
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Product
Table 78. Johnson & Johnson Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 79. Johnson & Johnson Recent Development
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Medtronic Company Details
Table 86. Medtronic Business Overview
Table 87. Medtronic Product
Table 88. Medtronic Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 89. Medtronic Recent Development
Table 90. Boston Scientific Company Details
Table 91. Boston Scientific Business Overview
Table 92. Boston Scientific Product
Table 93. Boston Scientific Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 94. Boston Scientific Recent Development
Table 95. Siemens Company Details
Table 96. Siemens Business Overview
Table 97. Siemens Product
Table 98. Siemens Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 99. Siemens Recent Development
Table 100. Biotronik Company Details
Table 101. Biotronik Business Overview
Table 102. Biotronik Product
Table 103. Biotronik Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 104. Biotronik Recent Development
Table 105. Koninklijke Philips Company Details
Table 106. Koninklijke Philips Business Overview
Table 107. Koninklijke Philips Product
Table 108. Koninklijke Philips Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 109. Koninklijke Philips Recent Development
Table 110. AtriCure Business Overview
Table 111. AtriCure Product
Table 112. AtriCure Company Details
Table 113. AtriCure Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 114. AtriCure Recent Development
Table 115. CardioFocus Company Details
Table 116. CardioFocus Business Overview
Table 117. CardioFocus Product
Table 118. CardioFocus Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 119. CardioFocus Recent Development
Table 120. MicroPort Scientific Company Details
Table 121. MicroPort Scientific Business Overview
Table 122. MicroPort Scientific Product
Table 123. MicroPort Scientific Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 124. MicroPort Scientific Recent Development
Table 125. Sichuan Jinjiang Electronic Science and Technology Company Details
Table 126. Sichuan Jinjiang Electronic Science and Technology Business Overview
Table 127. Sichuan Jinjiang Electronic Science and Technology Product
Table 128. Sichuan Jinjiang Electronic Science and Technology Revenue in Atrial Fibrillation Treatment Business (2015-2020) (Million US$)
Table 129. Sichuan Jinjiang Electronic Science and Technology Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atrial Fibrillation Treatment Market Share by Type: 2020 VS 2026
Figure 2. Medications Features
Figure 3. Non-Surgical Procedures Features
Figure 4. Surgical Procedures Features
Figure 5. Global Atrial Fibrillation Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Atrial Fibrillation Treatment Report Years Considered
Figure 10. Global Atrial Fibrillation Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Atrial Fibrillation Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Atrial Fibrillation Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Atrial Fibrillation Treatment Market Share by Players in 2019
Figure 15. Global Top Atrial Fibrillation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Atrial Fibrillation Treatment Revenue in 2019
Figure 17. North America Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Atrial Fibrillation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
心房細動（SPAF）治療における脳卒中予防の世界市場（～2026年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…- 心房細動（AF）診断の世界市場（～2026年） Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain. Factors such as aging of populati…
- 心房細動薬の世界市場（～2026年） Market Analysis and Insights: Global Atrial Fibrillation Drugs Market The global Atrial Fibrillation Drugs market size is projected to reach US$ 6158 million by 2026, from US$ 5987 million in 2020, at a CAGR of 2.7%% during 2021-2026. Global Atrial Fibrillation Drugs Scope and Market Size Atrial Fib…
- 肥満外科手術の世界市場（～2026年） Obesity is a medical condition which occurs due to excessive fat accumulation leading to adverse effect on health. Few of the prime reason for obesity are excessive food intake, less physical exercise and genetic susceptibility. According to the World Health Organization (WHO), the body mass index (…
- イラク医療（手術的処置）の世界市場（～2026年） Iraq is one of the fastest growing economies in Middle East and North Africa (MENA) attributed by the flourishing oil sector that is helping the domestic government to improve health care services. The Iraq health care system is managed by mixed initiatives of public and private sector; wherein the …